about
Organ-wide 3D-imaging and topological analysis of the continuous microvascular network in a murine lymph nodeOn-lattice simulation of T cell motility, chemotaxis, and trafficking in the lymph node paracortexSimulating T-cell motility in the lymph node paracortex with a packed lattice geometry.Spatially transformed fluorescence image data for ERK-MAPK and selected proteins within human epidermisMapping melanoma lymphoscintigraphy data onto a 3D anatomically based model.In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.Recombinant adeno-associated virus serotype 6 efficiently transduces primary human melanocytesThe use of HLA class I tetramers to design a vaccination strategy for melanoma patients.An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regenerationMonitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.Regulation of ERK-MAPK signaling in human epidermisDissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA.Augmentation with an ovine forestomach matrix scaffold improves histological outcomes of rotator cuff repair in a rat model.An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillancNew insights into the phenotype of human dendritic cell populations.Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404)Immunofluorescence identifies distinct subsets of endothelial cells in the human liverT cell responses in lymph nodes.The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver--a systematic review.Convergent chemo-enzymatic synthesis of mannosylated glycopeptides; targeting of putative vaccine candidates to antigen presenting cells.High level expression and purification of active recombinant human interleukin-15 in Pichia pastoris.Characterization of mesenchymal progenitor cell populations directly derived from human dermis.A multi-laboratory comparison of blood dendritic cell populations.Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever.Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop.The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.Cultured pericytes from human brain show phenotypic and functional differences associated with differential CD90 expression.Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.Corrigendum: Organ-wide 3D-imaging and topological analysis of the continuous microvascular network in a murine lymph node.Comprehensive analysis of MHC-II expression in healthy human skin.Cell-targeted platinum nanoparticles and nanoparticle clusters.MicroRNA regulation in human CD8+ T cell subsets--cytokine exposure alone drives miR-146a expression.Novel CD8+ T cell antagonists based on beta 2-microglobulin.
P50
Q27306661-DB687528-75F9-474A-A2D9-A1B1B2673642Q27318400-1CD3EE62-DBC4-44A6-955E-30492F45DBA4Q30488960-6901DEF2-BE1B-4B62-B1B2-6EF8631BDD2FQ31032505-C6386635-3E8A-49A7-9A28-435D9425EB0AQ31110251-38AED742-759C-45E5-A152-09240E06C876Q33178945-500906EF-DEBD-4046-80DE-94A7659B0E6AQ33855405-4D708493-29BC-4791-A12A-E4DF1D184AF5Q33902330-07793DAF-87DF-4DB9-A45E-4D20E0C77D77Q34706818-197CCFD2-3C5A-4311-9ED2-4DECC181247DQ35005955-D7948B23-468A-4374-8DC4-5CA5EB84AAD1Q35137191-07A62F09-741E-4C3B-9F50-99A4EBE136DFQ35147860-0946FE84-3B63-4D35-89FA-7C1F550010C9Q35589729-ED5BED30-D900-4939-8A83-2E0703E7A319Q35693584-DB88CFA8-705E-4BEA-81E8-2618CA922041Q35713209-ABEBAEDA-9E50-4219-9B6E-2F38C9F3F9ABQ35832390-EE4CF08E-7274-4B4C-A124-0CC6E1CAE2D1Q36190038-AB1E7900-196D-485A-AE1B-1E02870F156DQ36375260-9D9F2EAE-BCAE-48FC-9497-1215FD5399B7Q36526496-39FC16E3-5E2E-496D-AA6D-07FCE214A8A2Q37269347-2E143220-C8C6-4D77-B319-FE5C526710ACQ37695203-6C43129C-DDD9-4F8B-844E-BEDF387F63B8Q37787987-F1931ACA-5416-42E9-A6DB-6C240CAD3400Q38260237-03433ADE-2B2B-4FE1-99A7-E09BA477A358Q38297352-FED776F5-5401-48B4-8A9F-31CD10394E9DQ38810995-80554E20-77A3-42BA-86F9-65EE44AD5951Q39297684-C69405E8-31B4-4F77-BB12-8CE54F3BAEEDQ39754362-5D2AF70D-ACD7-45B9-B7CA-FF6B7557A095Q39883131-5F63C288-F8E9-4A9E-B402-2309B111D8C4Q40093738-EEA2B8E3-147B-478D-B9E4-E7E6590C7CA8Q40206871-6A9B5755-EE87-451B-808D-4CFCEA238DF6Q40794740-40F13AB9-0DE7-440F-AEE9-AB803095DAD1Q40841536-ADBC3DC0-8AFE-47E3-B4FD-476AF8A1E4A6Q41106399-9B03A066-1086-4D16-B7D2-A6F9A8A46A0BQ41896223-9FB65C7A-A337-4EF5-A75D-6B390646D2E1Q42200627-1B70BA10-54F3-455B-8557-46C36796B9E1Q42551003-D7B18387-28C0-4626-BFC7-3B6EACBF7FE2Q42556396-54DA454B-B8F5-434F-8BFC-7C314403618BQ42827235-EE1F1F11-F5F4-4CD4-A257-567714AF303FQ42974014-5D7127B9-5F01-419F-BBA1-55F0FB332905Q43933155-B9E601E9-E772-4779-BBEE-3551D8B5C2D9
P50
description
forsker
@nb
onderzoeker uit Nieuw-Zeeland
@nl
researcher
@en
հետազոտող
@hy
name
P. Rod Dunbar
@ast
P. Rod Dunbar
@nl
Rod Dunbar
@en
Rod Dunbar
@es
Rod Dunbar
@nb
type
label
P. Rod Dunbar
@ast
P. Rod Dunbar
@nl
Rod Dunbar
@en
Rod Dunbar
@es
Rod Dunbar
@nb
altLabel
P. Rod Dunbar
@en
prefLabel
P. Rod Dunbar
@ast
P. Rod Dunbar
@nl
Rod Dunbar
@en
Rod Dunbar
@es
Rod Dunbar
@nb
P106
P27
P31
P496
0000-0001-9626-2600